Entry Detail



General Information

Database ID:exR0000228
RNA Name:ADAM11
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):44758988End Site(bp):44781846
External Links:ENSG00000073670



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AGRN
chr1
1020120
1056118
+
CREBZF
chr11
85659708
85682908
-
CSDE1
chr1
114716913
114758676
-
FANCA
chr16
89737549
89816657
-
GHDC
chr17
42188799
42194532
-
GOLPH3
chr5
32124716
32174319
-
HCFC1
chrX
153947557
153971818
-
HDGFL3
chr15
83112738
83207823
-
KIAA1841
chr2
61065871
61138034
+
LMNB2
chr19
2427638
2456959
-
LRP6
chr12
12116025
12267044
-
MCC
chr5
113022099
113488823
-
MDC1
chr6
30699807
30717447
-
MDGA1
chr6
37630679
37699306
-
MT-ND1
chrMT
3307
4262
+
NISCH
chr3
52455118
52493068
+
NOP53
chr19
47745546
47757058
+
PLXNA1
chr3
126988594
127037392
+
SF3B3
chr16
70523791
70577670
+
SNX17
chr2
27370496
27377535
+
TLE3
chr15
70047790
70098176
-
TM9SF2
chr13
99446311
99564048
+
TMEM25
chr11
118531041
118547280
+
TNPO2
chr19
12699194
12724011
-
TUBB
chr6
30720352
30725426
+
UNC119B
chr12
120710458
120723640
+
YBX1
chr1
42682418
42703805
+
ZNF70
chr22
23738682
23751112
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
LINC02228
chr5
25087450
25190956
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.